Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study
<strong>Background<br></strong> Knowledge of the window of SARS-CoV-2 infectiousness is crucial in developing policies to curb transmission. Mathematical modelling based on scarce empirical evidence and key assumptions has driven isolation and testing policy, but real-world data ar...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2022
|
| _version_ | 1797108776026767360 |
|---|---|
| author | Hakki, S Zhou, J Jonnerby, J Singanayagam, A Barnett, JL Madon, KJ Koycheva, A Kelly, C Houston, H Nevin, S Fenn, J Kundu, R Crone, MA Ahmad, S Derqui-Fernandez, N Conibear, E Freemont, PS Taylor, GP Ferguson, N Zambon, M Barclay, WS Dunning, J Lalvani, A Badhan, A Varro, R Luca, C Quinn, V Cutajar, J Nichols, N Russell, J Grey, H Ketkar, A Miserocchi, G Tejpal, C Catchpole, H Nixon, K Di Biase, B Hopewell, T Narean, JS Samuel, J Timcang, K McDermott, E Bremang, S Hammett, S Evetts, S Kondratiuk, A |
| author_facet | Hakki, S Zhou, J Jonnerby, J Singanayagam, A Barnett, JL Madon, KJ Koycheva, A Kelly, C Houston, H Nevin, S Fenn, J Kundu, R Crone, MA Ahmad, S Derqui-Fernandez, N Conibear, E Freemont, PS Taylor, GP Ferguson, N Zambon, M Barclay, WS Dunning, J Lalvani, A Badhan, A Varro, R Luca, C Quinn, V Cutajar, J Nichols, N Russell, J Grey, H Ketkar, A Miserocchi, G Tejpal, C Catchpole, H Nixon, K Di Biase, B Hopewell, T Narean, JS Samuel, J Timcang, K McDermott, E Bremang, S Hammett, S Evetts, S Kondratiuk, A |
| author_sort | Hakki, S |
| collection | OXFORD |
| description | <strong>Background<br></strong>
Knowledge of the window of SARS-CoV-2 infectiousness is crucial in developing policies to curb transmission. Mathematical modelling based on scarce empirical evidence and key assumptions has driven isolation and testing policy, but real-world data are needed. We aimed to characterise infectiousness across the full course of infection in a real-world community setting.
<br><strong>Methods<br></strong>
The Assessment of Transmission and Contagiousness of COVID-19 in Contacts (ATACCC) study was a UK prospective, longitudinal, community cohort of contacts of newly diagnosed, PCR-confirmed SARS-CoV-2 index cases. Household and non-household exposed contacts aged 5 years or older were eligible for recruitment if they could provide informed consent and agree to self-swabbing of the upper respiratory tract. The primary objective was to define the window of SARS-CoV-2 infectiousness and its temporal correlation with symptom onset. We quantified viral RNA load by RT-PCR and infectious viral shedding by enumerating cultivable virus daily across the course of infection. Participants completed a daily diary to track the emergence of symptoms. Outcomes were assessed with empirical data and a phenomenological Bayesian hierarchical model.
<br><strong>Findings<br></strong>
Between Sept 13, 2020, and March 31, 2021, we enrolled 393 contacts from 327 households (the SARS-CoV-2 pre-alpha and alpha variant waves); and between May 24, 2021, and Oct 28, 2021, we enrolled 345 contacts from 215 households (the delta variant wave). 173 of these 738 contacts were PCR positive for more than one timepoint, 57 of which were at the start of infection and comprised the final study population. The onset and end of infectious viral shedding were captured in 42 cases and the median duration of infectiousness was 5 (IQR 3–7) days. Although 24 (63%) of 38 cases had PCR-detectable virus before symptom onset, only seven (20%) of 35 shed infectious virus presymptomatically. Symptom onset was a median of 3 days before both peak viral RNA and peak infectious viral load (viral RNA IQR 3–5 days, n=38; plaque-forming units IQR 3–6 days, n=35). Notably, 22 (65%) of 34 cases and eight (24%) of 34 cases continued to shed infectious virus 5 days and 7 days post-symptom onset, respectively (survival probabilities 67% and 35%). Correlation of lateral flow device (LFD) results with infectious viral shedding was poor during the viral growth phase (sensitivity 67% [95% CI 59–75]), but high during the decline phase (92% [86–96]). Infectious virus kinetic modelling suggested that the initial rate of viral replication determines the course of infection and infectiousness.
<br><strong>Interpretation<br></strong>
Less than a quarter of COVID-19 cases shed infectious virus before symptom onset; under a crude 5-day self-isolation period from symptom onset, two-thirds of cases released into the community would still be infectious, but with reduced infectious viral shedding. Our findings support a role for LFDs to safely accelerate deisolation but not for early diagnosis, unless used daily. These high-resolution, community-based data provide evidence to inform infection control guidance.
<br><strong>Funding<br></strong>
National Institute for Health and Care Research. |
| first_indexed | 2024-03-07T07:31:38Z |
| format | Journal article |
| id | oxford-uuid:42cae366-2272-4cb2-946a-6557eaf0e42d |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:31:38Z |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:42cae366-2272-4cb2-946a-6557eaf0e42d2023-02-04T11:19:02ZOnset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:42cae366-2272-4cb2-946a-6557eaf0e42dEnglishSymplectic ElementsElsevier2022Hakki, SZhou, JJonnerby, JSinganayagam, ABarnett, JLMadon, KJKoycheva, AKelly, CHouston, HNevin, SFenn, JKundu, RCrone, MAAhmad, SDerqui-Fernandez, NConibear, EFreemont, PSTaylor, GPFerguson, NZambon, MBarclay, WSDunning, JLalvani, ABadhan, AVarro, RLuca, CQuinn, VCutajar, JNichols, NRussell, JGrey, HKetkar, AMiserocchi, GTejpal, CCatchpole, HNixon, KDi Biase, BHopewell, TNarean, JSSamuel, JTimcang, KMcDermott, EBremang, SHammett, SEvetts, SKondratiuk, A<strong>Background<br></strong> Knowledge of the window of SARS-CoV-2 infectiousness is crucial in developing policies to curb transmission. Mathematical modelling based on scarce empirical evidence and key assumptions has driven isolation and testing policy, but real-world data are needed. We aimed to characterise infectiousness across the full course of infection in a real-world community setting. <br><strong>Methods<br></strong> The Assessment of Transmission and Contagiousness of COVID-19 in Contacts (ATACCC) study was a UK prospective, longitudinal, community cohort of contacts of newly diagnosed, PCR-confirmed SARS-CoV-2 index cases. Household and non-household exposed contacts aged 5 years or older were eligible for recruitment if they could provide informed consent and agree to self-swabbing of the upper respiratory tract. The primary objective was to define the window of SARS-CoV-2 infectiousness and its temporal correlation with symptom onset. We quantified viral RNA load by RT-PCR and infectious viral shedding by enumerating cultivable virus daily across the course of infection. Participants completed a daily diary to track the emergence of symptoms. Outcomes were assessed with empirical data and a phenomenological Bayesian hierarchical model. <br><strong>Findings<br></strong> Between Sept 13, 2020, and March 31, 2021, we enrolled 393 contacts from 327 households (the SARS-CoV-2 pre-alpha and alpha variant waves); and between May 24, 2021, and Oct 28, 2021, we enrolled 345 contacts from 215 households (the delta variant wave). 173 of these 738 contacts were PCR positive for more than one timepoint, 57 of which were at the start of infection and comprised the final study population. The onset and end of infectious viral shedding were captured in 42 cases and the median duration of infectiousness was 5 (IQR 3–7) days. Although 24 (63%) of 38 cases had PCR-detectable virus before symptom onset, only seven (20%) of 35 shed infectious virus presymptomatically. Symptom onset was a median of 3 days before both peak viral RNA and peak infectious viral load (viral RNA IQR 3–5 days, n=38; plaque-forming units IQR 3–6 days, n=35). Notably, 22 (65%) of 34 cases and eight (24%) of 34 cases continued to shed infectious virus 5 days and 7 days post-symptom onset, respectively (survival probabilities 67% and 35%). Correlation of lateral flow device (LFD) results with infectious viral shedding was poor during the viral growth phase (sensitivity 67% [95% CI 59–75]), but high during the decline phase (92% [86–96]). Infectious virus kinetic modelling suggested that the initial rate of viral replication determines the course of infection and infectiousness. <br><strong>Interpretation<br></strong> Less than a quarter of COVID-19 cases shed infectious virus before symptom onset; under a crude 5-day self-isolation period from symptom onset, two-thirds of cases released into the community would still be infectious, but with reduced infectious viral shedding. Our findings support a role for LFDs to safely accelerate deisolation but not for early diagnosis, unless used daily. These high-resolution, community-based data provide evidence to inform infection control guidance. <br><strong>Funding<br></strong> National Institute for Health and Care Research. |
| spellingShingle | Hakki, S Zhou, J Jonnerby, J Singanayagam, A Barnett, JL Madon, KJ Koycheva, A Kelly, C Houston, H Nevin, S Fenn, J Kundu, R Crone, MA Ahmad, S Derqui-Fernandez, N Conibear, E Freemont, PS Taylor, GP Ferguson, N Zambon, M Barclay, WS Dunning, J Lalvani, A Badhan, A Varro, R Luca, C Quinn, V Cutajar, J Nichols, N Russell, J Grey, H Ketkar, A Miserocchi, G Tejpal, C Catchpole, H Nixon, K Di Biase, B Hopewell, T Narean, JS Samuel, J Timcang, K McDermott, E Bremang, S Hammett, S Evetts, S Kondratiuk, A Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study |
| title | Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study |
| title_full | Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study |
| title_fullStr | Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study |
| title_full_unstemmed | Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study |
| title_short | Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study |
| title_sort | onset and window of sars cov 2 infectiousness and temporal correlation with symptom onset a prospective longitudinal community cohort study |
| work_keys_str_mv | AT hakkis onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT zhouj onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT jonnerbyj onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT singanayagama onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT barnettjl onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT madonkj onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT koychevaa onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT kellyc onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT houstonh onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT nevins onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT fennj onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT kundur onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT cronema onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT ahmads onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT derquifernandezn onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT conibeare onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT freemontps onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT taylorgp onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT fergusonn onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT zambonm onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT barclayws onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT dunningj onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT lalvania onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT badhana onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT varror onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT lucac onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT quinnv onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT cutajarj onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT nicholsn onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT russellj onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT greyh onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT ketkara onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT miserocchig onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT tejpalc onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT catchpoleh onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT nixonk onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT dibiaseb onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT hopewellt onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT nareanjs onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT samuelj onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT timcangk onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT mcdermotte onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT bremangs onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT hammetts onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT evettss onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy AT kondratiuka onsetandwindowofsarscov2infectiousnessandtemporalcorrelationwithsymptomonsetaprospectivelongitudinalcommunitycohortstudy |